Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1507
-
Total 13F shares, excl. options
-
975M
-
Shares change
-
-17.6M
-
Total reported value, excl. options
-
$61.5B
-
Value change
-
-$1.19B
-
Put/Call ratio
-
1.39
-
Number of buys
-
680
-
Number of sells
-
-792
-
Price
-
$63.19
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2020
1,759 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2020.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,507 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 975M shares
of 1.24B outstanding shares and own 78.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (118M shares), Capital Research Global Investors (117M shares), VANGUARD GROUP INC (103M shares), STATE STREET CORP (57M shares), Capital International Investors (48.5M shares), Capital World Investors (39.3M shares), GEODE CAPITAL MANAGEMENT, LLC (20M shares), Bank of New York Mellon Corp (16.4M shares), NORTHERN TRUST CORP (15.9M shares), and NORGES BANK (13.2M shares).
This table shows the top 1507 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.